Jove
Visualize
Contact Us

Related Experiment Videos

Systemic management of posterior uveitis.

Julia Song1

  • 1Duke University Medical Center, Durham, NC 27710, USA. Song0012@notes.duke.edu

Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
|September 11, 2003
PubMed
Summary

Corticosteroids are first-line for uveitis, but systemic immunosuppressants like methotrexate are key for long-term posterior uveitis management, reducing steroid dependence and relapse rates.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Teasing out factors differentiating pathologic from benign pneumatosis intestinalis.

The journal of trauma and acute care surgery·2025
Same author

Diffuse idiopathic skeletal hyperostosis (DISH): Detection on dental radiologic examinations in two older adults and overview of the literature.

Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry·2024
Same author

Oxymetazoline hydrochloride ophthalmic solution, 0.1%, boosts the effects of botulinum toxin on blepharospasm: a case series.

Journal of medical case reports·2022
Same author

Intraocular pressure improvement in patients receiving teprotumumab for the treatment of thyroid eye disease: a case series.

Journal of medical case reports·2022
Same author

Cancer in the Shadow of COVID: Early-Stage Breast and Prostate Cancer Patient Perspectives on Surgical Delays Due to COVID-19.

Annals of surgical oncology·2021
Same author

Rhopressa-induced corneal edema: a case report.

Journal of medical case reports·2021
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Ophthalmology
  • Immunology

Background:

  • Corticosteroids are standard first-line uveitis treatment due to rapid action and safety.
  • Systemic immunosuppressive agents are crucial for managing posterior uveitis.

Purpose of the Study:

  • To review systemic agents for uveitis treatment, including prednisone, methotrexate, cyclosporine, and azathioprine.

Main Methods:

  • Literature review utilizing the Medline database.
  • Inclusion of thirty-eight relevant references.

Main Results:

  • Immunosuppressants require weeks for full effect and are indicated for anticipated long-term therapy.
  • Adding immunosuppressants allows for prednisone reduction and discontinuation.
  • Combination immunosuppressant therapy can lower relapse rates.

Conclusions:

  • Systemic immunosuppressants are vital for long-term uveitis management, enabling steroid-sparing strategies.
  • While effective, immunosuppressants carry risks and necessitate vigilant patient monitoring.

Related Experiment Videos